RPID

Rapid Micro Biosystems, Inc. [RPID] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

RPID Stock Summary

Top 10 Correlated Stocks

RPID


In the News

09:48 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.63% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

04:05 26 Mar 2023 RPID

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2022 financial results prior to the market open on Friday, March 3, 2023.

08:00 26 Mar 2023 RPID

Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference

LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference.

01:03 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Q3 2022 Earnings Call Transcript

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - JPMorgan Stephanie Yan - Cowen Operator Hello. My name is Lisa and I will be your conference operator today.

09:47 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.70% and 20.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

09:10 26 Mar 2023 RPID

Hill International, Rapid Micro Biosystems See Activist Investor Action

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

11:03 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) CEO Rob Spignesi on Q2 2022 Results - Earnings Call Transcript

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Stephanie Yan - Cowen Rachel Cascio - JPMorgan Operator Ladies and gentlemen, thank you for standing by and welcome to the Rapid Micro Biosystems Second Quarter 2022 Earnings Conference Call. I would now like to turn the call over to Mike Beaulieu, Investor Relations.

09:47 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Lags Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 11.43% and 24.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

01:51 26 Mar 2023 RPID

Rapid Micro Biosystems Inc. (RPID) CEO Robert Spignesi on Q1 2022 Results - Earnings Call Transcript

Rapid Micro Biosystems Inc. (NASDAQ:RPID ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Noah Burhance - JPMorgan Operator Good day, and thank you for standing by. Welcome to the Rapid Micro Biosystems First Quarter 2022 Earnings Conference Call.

04:10 26 Mar 2023 RPID

Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022

LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the market open.

RPID Financial details

Company Rating
Neutral
Market Cap
52.74M
Income
-60.81M
Revenue
17.13M
Book val./share
3.87
Cash/share
2.56
Dividend
-
Dividend %
-
Employees
202
Optionable
No
Shortable
Yes
Earnings
03 Mar 2023
P/E
-0.9
Forward P/E
-
PEG
0.36
P/S
2.96
P/B
0.3
P/C
0.49
P/FCF
-0.8
Quick Ratio
7.86
Current Ratio
9.5
Debt / Equity
0.16
LT Debt / Equity
0.04
-
-
EPS (TTM)
-1.43
EPS next Y
-
EPS next Q
-
EPS this Y
-24.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-7.7%
EPS Q/Q
2.63%
-
-
-
-
SMA20
10.26%
SMA50
-2.27%
SMA100
-58.65%
Inst Own
57.63%
Inst Trans
-2.7%
ROA
-29%
ROE
-29%
ROC
-0.32%
Gross Margin
-47%
Oper. Margin
-337%
Profit Margin
-328%
Payout
-
Shs Outstand
42.19M
Shs Float
13.74M
-
-
-
-
Target Price
8
52W Range
1.01-7.12
52W High
-82.14%
52W Low
+25%
RSI
48.96
Rel Volume
0.46
Avg Volume
93.96K
Volume
43.62K
Perf Week
3.31%
Perf Month
0%
Perf Quarter
-61.3%
Perf Half Y
-64.29%
-
-
-
-
Beta
-
-
-
Volatility
0.08%, 0.11%
Prev Close
0.81%
Price
1.25
Change
-1.65%

RPID Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.610.60.860.4
Net income per share
-0.79-1.38-2.73-1.43
Operating cash flow per share
-0.78-1.15-2.04-1.38
Free cash flow per share
-0.85-1.18-2.04-1.54
Cash per share
0.461.677.182.56
Book value per share
-0.030.928.23.87
Tangible book value per share
-0.030.928.23.87
Share holders equity per share
-0.030.928.23.87
Interest debt per share
0.751.05-0.10.23
Market cap
577.01M577.01M286.89M47.97M
Enterprise value
582.35M571.74M108.5M28.88M
P/E ratio
-27.25-15.56-3.9-0.79
Price to sales ratio
34.9435.8912.352.8
POCF ratio
-27.29-18.62-5.22-0.82
PFCF ratio
-25.26-18.21-5.22-0.73
P/B Ratio
-795.8723.251.30.29
PTB ratio
-795.8723.251.30.29
EV to sales
35.2735.564.671.69
Enterprise value over EBITDA
-34.44-17.87-1.46-0.51
EV to operating cash flow
-27.54-18.45-1.97-0.49
EV to free cash flow
-25.49-18.04-1.97-0.44
Earnings yield
-0.04-0.06-0.26-1.27
Free cash flow yield
-0.04-0.05-0.19-1.36
Debt to equity
-44.711.820.090.16
Debt to assets
1.020.650.080.14
Net debt to EBITDA
-0.320.162.390.34
Current ratio
2.24412.017.27
Interest coverage
-7.85-8.8617.82-35.56
Income quality
10.840.750.96
Dividend Yield
0000
Payout ratio
0000
Sales general and administrative to revenue
0.540.620.771.57
Research and developement to revenue
0.330.410.420.75
Intangibles to total assets
0000
Capex to operating cash flow
0.080.0200.12
Capex to revenue
-0.1-0.040-0.39
Capex to depreciation
-1.16-0.46-0.01-2.38
Stock based compensation to revenue
0.030.030.080.23
Graham number
0.695.3422.4211.16
ROIC
-5.34-5.710.4-0.48
Return on tangible assets
-0.67-0.53-0.3-0.32
Graham Net
-0.50.326.862.28
Working capital
13.08M46.61M199.96M119.53M
Tangible asset value
-725K24.82M220.98M164.17M
Net current asset value
-8.8M16.97M197.94M112.1M
Invested capital
-24.56100.05
Average receivables
05.35M5.39M5.19M
Average payables
03.84M4.21M4.69M
Average inventory
07.36M12.32M18.43M
Days sales outstanding
108.74131.3278.63114.38
Days payables outstanding
69.9967.5346.4877.17
Days of inventory on hand
125.37135.51184.67301.22
Receivables turnover
3.362.784.643.19
Payables turnover
5.225.47.854.73
Inventory turnover
2.912.691.981.21
ROE
29.2-1.49-0.33-0.37
Capex per share
-0.06-0.030-0.16

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric History 2021-12-312022-03-312022-06-302022-09-30 2022-12-31
Revenue per share
0.120.10.090.110.1
Net income per share
-0.35-0.35-0.31-0.38-0.39
Operating cash flow per share
-0.31-0.4-0.35-0.36-0.27
Free cash flow per share
-0.31-0.45-0.4-0.39-0.29
Cash per share
4.623.843.392.72.56
Book value per share
5.284.914.594.213.87
Tangible book value per share
5.284.914.594.213.87
Share holders equity per share
5.284.914.594.213.87
Interest debt per share
00.190.20.210.21
Market cap
445.37M286.52M182.72M137.33M47.97M
Enterprise value
266.98M232.03M141.46M119.72M28.88M
P/E ratio
-7.62-4.8-3.49-2.1-0.73
Price to sales ratio
85.5268.8847.3428.9810.97
POCF ratio
-34.56-17.05-12.19-9.09-4.12
PFCF ratio
-34.56-14.96-10.76-8.23-3.85
P/B Ratio
2.021.380.940.770.29
PTB ratio
2.021.380.940.770.29
EV to sales
51.2655.7836.6525.266.6
Enterprise value over EBITDA
-18.88-16.19-10.87-7.97-1.96
EV to operating cash flow
-20.72-13.81-9.44-7.93-2.48
EV to free cash flow
-20.72-12.11-8.33-7.17-2.32
Earnings yield
-0.03-0.05-0.07-0.12-0.34
Free cash flow yield
-0.03-0.07-0.09-0.12-0.26
Debt to equity
0.090.110.110.130.16
Debt to assets
0.080.10.10.110.14
Net debt to EBITDA
12.623.83.171.171.29
Current ratio
12.0112.5713.459.57.27
Interest coverage
766.11-1.36K-1.41K-29.37-20.77
Income quality
0.881.131.140.920.71
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.111.461.661.521.63
Research and developement to revenue
0.550.850.770.630.78
Intangibles to total assets
00000
Capex to operating cash flow
00.140.130.110.07
Capex to revenue
0-0.57-0.52-0.33-0.19
Capex to depreciation
0-4.2-2.91-2.16-0.94
Stock based compensation to revenue
0.130.240.330.140.25
Graham number
6.446.255.646.035.81
ROIC
0.12-0.15-0.12-0.12-0.13
Return on tangible assets
-0.06-0.06-0.06-0.08-0.09
Graham Net
4.423.583.222.492.28
Working capital
199.96M172.03M158.73M129.37M119.53M
Tangible asset value
220.98M207.07M194.97M179.02M164.17M
Net current asset value
197.94M163.92M150.31M121.68M112.1M
Invested capital
00.040.040.050.05
Average receivables
5.01M4.54M4.2M4.52M5.04M
Average payables
3.1M3.75M3.19M3.25M4.55M
Average inventory
14.92M16.69M19.5M21.11M21.06M
Days sales outstanding
86.4988.2100.8789.53110.47
Days payables outstanding
45.5452.5149.9943.8570.04
Days of inventory on hand
180.96262377.16249.99273.38
Receivables turnover
1.041.020.891.010.81
Payables turnover
1.981.711.82.051.29
Inventory turnover
0.50.340.240.360.33
ROE
-0.07-0.07-0.07-0.09-0.1
Capex per share
0-0.06-0.05-0.04-0.02

RPID Frequently Asked Questions

What is Rapid Micro Biosystems, Inc. stock symbol ?

Rapid Micro Biosystems, Inc. is a US stock , located in Lowell of Ma and trading under the symbol RPID

Is Rapid Micro Biosystems, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $8. The lowest prediction is $8 and the highest is $8

What is RPID stock prediction ?

What is Rapid Micro Biosystems, Inc. stock quote today ?

Rapid Micro Biosystems, Inc. stock price is $1.25 today.

Is Rapid Micro Biosystems, Inc. stock public?

Yes, Rapid Micro Biosystems, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap